BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6407435)

  • 41. Changes in purine nucleoside content in human myocardial efflux during pacing-induced ischemia.
    Remme WJ; De Jong JW; Verdouw PD
    Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 12():409-13. PubMed ID: 1031994
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of glucagon on myocardial metabolism in diagnostic cardiac pacing.
    Andĕl M; Brodan V; Fabián J; Veselková A
    Cor Vasa; 1982; 24(4):277-81. PubMed ID: 7140310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prostacyclin and variant angina.
    Numano F; Nomura S; Aizawa T; Fujii J; Yajima M
    Ann N Y Acad Sci; 1985; 454():135-45. PubMed ID: 3865605
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methodological assessment and applications of a radioimmunoassay for thromboxane (TxB2) to measurement of TxB2 release by platelets.
    Giannessi D; De Caterina R; Gazzetti P; Bernini W; Masini S; Zucchelli GC
    J Nucl Med Allied Sci; 1982; 26(1):25-33. PubMed ID: 7108634
    [No Abstract]   [Full Text] [Related]  

  • 45. Haemodynamic and metabolic effects of dazoxiben at rest and during atrial pacing.
    Kiff PS; Bergman G; Atkinson L; Jewitt DE; Westwick J; Kakkar VV
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):73S-77S. PubMed ID: 6681708
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pacing induced angina and platelet reactivity.
    Thaulow E; Dale J; Kjekshus J; Simonsen S; Hovig T; Solum NO
    Scand J Clin Lab Invest; 1982 Dec; 42(8):607-11. PubMed ID: 7167726
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute administration of 17beta-estradiol reduces endothelin-1 release during pacing-induced ischemia.
    Rosano GM; Gebara O; Sheiban I; Silvestri A; Wajngarten M; Vitale C; Aldrighi JM; Ramires AF; Fini M; Mercuro G
    Int J Cardiol; 2007 Mar; 116(1):34-9. PubMed ID: 16814412
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma thromboxane B2 levels and atherosclerotic disorders.
    Numano F; Omori K; Nishiyama K; Kishi Y; Shimokado K; Numano F; Yajima M; Maezawa H
    Paroi Arterielle; 1981; 7(3):99-105. PubMed ID: 6122194
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease.
    Sciulli MG; Renda G; Capone ML; Tacconelli S; Ricciotti E; Manarini S; Evangelista V; Rebuzzi A; Patrignani P
    Clin Pharmacol Ther; 2006 Aug; 80(2):115-25. PubMed ID: 16890573
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Platelet release and thromboxane synthesis in symptomatic coronary artery disease.
    de Boer AC; Turpie AG; Butt RW; Johnston RV; Genton E
    Circulation; 1982 Aug; 66(2):327-33. PubMed ID: 6212161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of platelet number and haematocrit on whole blood thromboxane synthesis.
    Carter AJ; Hanley SP
    Thromb Haemost; 1985 Apr; 53(2):225-7. PubMed ID: 4024033
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of timolol on platelets in coronary sinus blood and on myocardial ischemia during pacing-induced angina.
    Thaulow E; Dale J
    Acta Med Scand; 1984; 216(2):193-8. PubMed ID: 6496177
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thromboxane A2 as an enhancing factor of coronary vasospasticity in variant angina.
    Ohmori M; Kuzuya T; Kodama K; Nanto S; Kamada T; Tada M
    Jpn Circ J; 1987 May; 51(5):495-502. PubMed ID: 3626009
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Myoglobin release in patients with angina pectoris following short-term ischaemia by pacing to angina.
    Sylvén C; Berglund B; Kaijser L
    Clin Physiol; 1984 Jun; 4(3):221-6. PubMed ID: 6540152
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Failure of thromboxane A2 blockade to prevent attacks of vasospastic angina.
    Chierchia S; de Caterina R; Crea F; Patrono C; Maseri A
    Circulation; 1982 Oct; 66(4):702-5. PubMed ID: 7116586
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Levels of neuropeptide Y and thromboxane B2 in patients with variant angina].
    Salomon P; Halawa B
    Pol Arch Med Wewn; 1998 Oct; 100(4):313-20. PubMed ID: 10335040
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coronary vasoconstrictor response to cold pressor test in variant angina: lack of relation to intracoronary thromboxane concentrations.
    De Servi S; Ferrario M; Rondanelli R; Corsico G; Poma E; Ghio S; Mussini A; Angoli L; Bramucci E; Bré E
    Am Heart J; 1987 Sep; 114(3):511-5. PubMed ID: 3630891
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Myocardial release of lactate, inosine and hypoxanthine during atrial pacing and exercise-induced angina.
    Kugler G
    Circulation; 1979 Jan; 59(1):43-9. PubMed ID: 758123
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of nitroglycerin on myocardial release of inosine, hypoxanthine and lactate during pacing-induced angina.
    Kugler G
    Basic Res Cardiol; 1978; 73(5):523-33. PubMed ID: 103536
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Biochemistry of coronary artery disease--prostaglandins].
    Tada M; Kuzuya T; Ohmori M
    Rinsho Byori; 1983 Aug; 31(8):854-9. PubMed ID: 6361336
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.